Kayne Anderson Rudnick Investment Management
DGX icon

Kayne Anderson Rudnick Investment Management’s Quest Diagnostics DGX Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
4,959
+3,566
+256% +$700K ﹤0.01% 402
2026
Q1 		$273K Sell
1,393
-654
-32% -$127K ﹤0.01% 482
2025
Q4 		$355K Sell
2,047
-763
-27% -$139K ﹤0.01% 469
2025
Q3 		$536K Sell
2,810
-1,470
-34% -$261K ﹤0.01% 438
2025
Q2 		$769K Sell
4,280
-1,310
-23% -$228K ﹤0.01% 401
2025
Q1 		$946K Buy
+5,590
New +$918K ﹤0.01% 388
2022
Q2 		– Sell
-8
Closed -$1K – 620
2022
Q1 		$1K Buy
+8
New +$1.11K ﹤0.01% 625
2020
Q1 		– Sell
-17
Closed -$2K – 626
2019
Q4 		$2K Buy
+17
New +$1.77K ﹤0.01% 563
2013
Q4 		– Sell
-214,493
Closed -$13.3M – 289
2013
Q3 		$13.3M Sell
214,493
-1,451
-0.7% -$86.8K 0.25% 106
2013
Q2 		$13.1M Buy
+215,944
New +$12.9M 0.27% 101

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's DGX Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management increased its Quest Diagnostics (DGX) stake by 256% in Q2 2026, buying an estimated $700K and bringing the position to 4,959 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Kayne Anderson Rudnick Investment Management first reported a position in DGX in Q2 2013 and has held it in 10 quarters since. The position peaked at $13.3M in Q3 2013. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 4,959 shares of Quest Diagnostics worth $1.05M as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management bought 3,566 Quest Diagnostics shares in Q2 2026, an estimated $700K.
  • Quest Diagnostics made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #402 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 10 quarters since.
  • Kayne Anderson Rudnick Investment Management's Quest Diagnostics position peaked at $13.3M in Q3 2013.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.